IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 6303 
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

RESEARCH ARTICLE

A study of potential drug-drug interactions among hospitalized cardiac patients in a teaching hospital in Western Nepal

Sharma Sushmita, Chhetri Himal Paudel, Alam Kadir

Year : 2014| Volume: 46| Issue : 2 | Page no: 152-156

   This article has been cited by
 
1 Potentially Harmful Drug–Drug Interactions and Their Associated Factors Among Hospitalized Cardiac Patients: A Cross-Sectional Study
Abdulrahman Kalash, Aly Abdelrahman, Ibrahim Al-Zakwani, Yousuf Al Suleimani
Drugs - Real World Outcomes. 2023;
[Pubmed]  [Google Scholar] [DOI]
2 Assessment of Potential Drug-drug Interactions (pDDIs) and Their Risk Factors Among Hospitalized Cardiac Patients in a Tertiary-care Center of Central India: A Retrospective Record-based Study
Ajaya Kumar Sahoo, Alok Singh, Dhyuti Gupta, Suryaprakash Dhaneria, Prachi Arunima
Hospital Pharmacy. 2023;
[Pubmed]  [Google Scholar] [DOI]
3 Drug-related problems and its predictors among hospitalized heart failure patients at Jimma Medical Center, South West Ethiopia: prospective interventional study
Birbirsa Sefera, Mestawet Getachew, Yadeta Babu, Firomsa Bekele, Korinan Fanta
BMC Cardiovascular Disorders. 2022; 22(1)
[Pubmed]  [Google Scholar] [DOI]
4 Prevalence and factors associated with adverse drug reactions among heart failure patients hospitalized at Mbarara Regional Referral Hospital, Uganda
Efrata Ashuro Shegena, Konjit Abebe Nigussie, Robert Tamukong, Boniface Amanee Elias Lumori, Tadele Mekuriya Yadesa
BMC Cardiovascular Disorders. 2022; 22(1)
[Pubmed]  [Google Scholar] [DOI]
5 Potential drug-drug interactions among patients with spontaneous intracerebral hemorrhage treated at the Neurological Intensive Care Unit: a single-center experience
Dejan Z. Aleksic, Miloš N. Milosavljevic, Slobodan M. Jankovic, Ana D. Azanjac Arsic, Srdjan M. Stefanovic
Brazilian Journal of Pharmaceutical Sciences. 2022; 58
[Pubmed]  [Google Scholar] [DOI]
6 Reintroduction of Post-Baccalaureate Doctor of Pharmacy (PharmD, Post-Bac) Program in Nepal: Exploration of the Obstacles and Solutions to Move Forward
Sunil Shrestha, Sweta Shrestha, Binaya Sapkota, Rajani Shakya, Rohullah Roien, Mohamed Izham Mohamed Ibrahim
Advances in Medical Education and Practice. 2022; Volume 13: 159
[Pubmed]  [Google Scholar] [DOI]
7 Data Sharing and Privacy in Pharmaceutical Studies
Rufan Chen, Yi Zhang, Zuochao Dou, Feng Chen, Kang Xie, Shuang Wang
Current Pharmaceutical Design. 2021; 27(7): 911
[Pubmed]  [Google Scholar] [DOI]
8 A PROSPECTIVE OBSERVATIONAL STUDY ON THE ASSESSMENT OF POTENTIAL DRUG-DRUG INTERACTIONS AND MANAGEMENT OF POST-COMPLICATIONS IN STROKE PATIENTS AT A TERTIARY CARE TEACHING HOSPITAL
MAHE NAAZ SULTANA, SABA YOUNUS QURESHI, IQRA FATIMA, WAJIDA JABEEN, MOHAMMED OBAID
International Journal of Pharmacy and Pharmaceutical Sciences. 2021; : 8
[Pubmed]  [Google Scholar] [DOI]
9 Potential drug–drug interactions in patients with cardiovascular diseases: findings from a prospective observational study
Zarka Akbar, Sundas Rehman, Asad Khan, Amjad Khan, Muhammad Atif, Nafees Ahmad
Journal of Pharmaceutical Policy and Practice. 2021; 14(1)
[Pubmed]  [Google Scholar] [DOI]
10 Prevalence and characteristics of drug-drug interactions among hospitalised patients in the Capital Region of Denmark
Hans Kristian Råket Pedersen, Anne Mette Skov Sørensen, Astrid Blicher Schelde, Martin Erik Nyeland, Espen Jimenez-Solem
Adverse Drug Reaction Bulletin. 2021; Publish Ah
[Pubmed]  [Google Scholar] [DOI]
11 Assessing Drug-Drug Interaction Potential among Patients Admitted to Surgery Departments in Three Palestinian Hospitals
Abdullah K. Rabba, Ayeshe M. Abu Hussein, Bayan K. Abu Sbeih, Somaya I. Nasser
BioMed Research International. 2020; 2020: 1
[Pubmed]  [Google Scholar] [DOI]
12 Impact of SLCO4C1 Genotypes, Creatinine, and Spironolactone on Digoxin Population Pharmacokinetic Variables in Patients With Cardiac Insufficiency
Pengqiang Du, Aifeng Wang, Yongcheng Ma, Ao Jia, Yafei Li, Xingang Li
Clinical Therapeutics. 2020; 42(9): 1799
[Pubmed]  [Google Scholar] [DOI]
13 Drug scheduling by nurses and drug interactions in patients with cardiovascular diseases
Natália da Palma Sobrinho, Juliana Faria Campos, Rafael Celestino da Silva
Revista Brasileira de Enfermagem. 2020; 73(5)
[Pubmed]  [Google Scholar] [DOI]
14 A Prospective Analysis of Potential and Observed Drug-Drug Interactions, Adverse Events and its Associated Risk Factors in Hospitalized Cardiology Patients in Benin
Aurel C.E. Allabi, Yessoufou Tchabi, Murielle Hounkponou, Rebecca Quenum, Jeanne Vehounkpe-Sacca
Current Drug Safety. 2020; 15(3): 190
[Pubmed]  [Google Scholar] [DOI]
15

Clinical Pharmacy Education and Practice in Nepal: A Glimpse into Present Challenges and Potential Solutions

Sunil Shrestha, Deepa Shakya, Subish Palaian
Advances in Medical Education and Practice. 2020; Volume 11: 541
[Pubmed]  [Google Scholar] [DOI]
16 Assessment of potential drug–drug interactions and its associated factors in the hospitalized cardiac patients
Ghulam Murtaza,Muhammad Yasir Ghani Khan,Saira Azhar,Shujaat Ali Khan,Tahir M. Khan
Saudi Pharmaceutical Journal. 2015;
[Pubmed]  [Google Scholar] [DOI]

 

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow